Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview
Author:
Funder
University of Sharjah
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s10238-022-00821-4.pdf
Reference206 articles.
1. Khateeb J, Li Y, Zhang H. Emerging SARS-CoV-2 variants of concern and potential intervention approaches. Crit Care. 2021;25:244.
2. WHO. Coronavirus disease (COVID-19) pandemic, 2021.
3. Wang Z, Deng H, Ou C, et al. Clinical symptoms, comorbidities and complications in severe and non-severe patients with COVID-19: a systematic review and meta-analysis without cases duplication. Medicine (Baltimore). 2020;99:e23327.
4. Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–5.
5. Eskandari A, Brojakowska A, Bisserier M, et al. Retrospective analysis of demographic factors in COVID-19 patients entering the Mount Sinai Health System. PLoS ONE. 2021;16:e0254707.
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The influence of comorbid diseases on the profiles of signaling biomarkers (macrophage-derived chemokine, interferon-γ-induced protein 10 kD, soluble CD40 ligand, vascular endothelial growth factor) and severity in patients with COVID-19: clinical studies;HERALD of North-Western State Medical University named after I.I. Mechnikov;2024-01-13
2. Assessment of Some Risk Factors and Biological Predictors in the Post COVID-19 Syndrome in Asthmatic Patients;Journal of Personalized Medicine;2023-12-22
3. Immunomodulatory macrophages and Treg in pulmonary hypertension;Comparative Clinical Pathology;2023-11-24
4. COVID-19 and health care–related financial toxicity in the United States: Evidence from the 2022 National Health Interview Survey;American Journal of Infection Control;2023-11
5. Multimorbidity and Serological Response to SARS-CoV-2 Nine Months after 1st Vaccine Dose: European Cohort of Healthcare Workers—Orchestra Project;Vaccines;2023-08-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3